The Role of Pregnancy-induced Gallbladder Dysmotility in the Pathophysiology of Gestational Diabetes Mellitus
NCT04108065 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2020-12-21
Summary
The primary aim of the study is to evaluate postprandial gallbladder emptying and plasma concentrations of the glucose-lowering and satiety-promoting gut hormone glucagon-like peptide 1 (GLP-1) during third trimester of pregnancy in women with gestational diabetes mellitus (GDM) compared with age and body mass index (BMI)-matched pregnant control women with normal glucose tolerance (NGT).
Conditions
- Gestational Diabetes Mellitus
Sponsors & Collaborators
-
University Hospital, Gentofte, Copenhagen
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-10-02
- Primary Completion
- 2020-10-30
- Completion
- 2020-10-30
Countries
- Denmark
Study Locations
More Related Trials
-
Effect of Bile Acids on GLP-1 Secretion
NCT01666223 ·Status: COMPLETED ·Phase: NA
-
Study of Postprandial Incretin Response in Women With Gestational Diabetes
NCT01274052 ·Status: COMPLETED
-
Importance of Meal Fat Content and Gall Bladder Emptying for Postprandial GLP-1 Secretion in Type 2 Diabetes Patients
NCT01374594 ·Status: COMPLETED
-
The Anatomical Location, Cellular Origin and Molecular Basis of Gut-derived Glucagon Secretion
NCT03181191 ·Status: COMPLETED ·Phase: NA
-
Glucagon Responses During Oral- and iv Glucose in Patients With Type 1 Diabetes
NCT00704795 ·Status: UNKNOWN
-
Hepatic Metabolic Changes in Response to Glucagon Infusion
NCT03526445 ·Status: COMPLETED ·Phase: NA
-
The Effect of GLP-1 on the Inhibition of Glucagon Secretion
NCT01507597 ·Status: COMPLETED ·Phase: NA
-
Effect of Glucagon-like Peptide 2 on Gallbladder Motility After a Meal in Young, Healthy Male Subjects
NCT03682172 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Endogenous Glucoseproduction in Patients With Type 2 Diabetes Mellitus During Oral Glucose and iv. Glucose Infusion
NCT02010827 ·Status: COMPLETED
-
Involvement of Steatosis-induced Glucagon Resistance in Hyperglucagonaemia
NCT02337660 ·Status: COMPLETED ·Phase: NA
-
The Role of Small Intestinal Endocrine Cells in Type 2 Diabetic Hyperglucagonemia
NCT00639613 ·Status: COMPLETED
-
Effect of Bile Acid Sequestration on Postprandial GLP-1 Secretion, Glucose Homeostasis and Gut Microbiota
NCT02061124 ·Status: COMPLETED ·Phase: NA
-
The Role of Metformin and Colesevelam in Human GLP-1 Secretion
NCT02050074 ·Status: COMPLETED ·Phase: PHASE4
-
Physiology of GIP(1-30)NH2 in Humans
NCT04792762 ·Status: COMPLETED ·Phase: NA
-
Separate and Combined Extrapancreatic Effects of the Incretin Hormones
NCT05177653 ·Status: COMPLETED ·Phase: NA
-
Effect of Bile Acid Secretion and Sequestration on GLP-1 Secretion
NCT02445508 ·Status: COMPLETED ·Phase: NA
-
The Effect of HMG-CoA Reductase Inhibition on Postprandial GLP-1 Secretion
NCT03018444 ·Status: COMPLETED ·Phase: NA
-
Intact Liver Innervation and Glucose and Glucagon-like Peptide-1 (GLP-1) Induced Insulin Secretion
NCT01176708 ·Status: UNKNOWN ·Phase: NA
-
GIP, GLP-1 and GLP-2 in Type 2 Diabetic Hyperglucagonemia
NCT00716170 ·Status: COMPLETED
-
The Effect of Insulin-induced Hypoglycaemia on Gut-derived Glucagon Secretion (Px-Hypo)
NCT04064203 ·Status: COMPLETED ·Phase: NA
-
Intact Vagal Innervation for and Glucagon-like Peptide-1 (GLP-1) Effects
NCT01176760 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Gastric Bypass Surgery on the Glucose Metabolism Seen in Patients With Type 2 Diabetes
NCT00810823 ·Status: COMPLETED
-
Development and Evaluation of a Glucagon Sensitivity Test in Individuals With and Without Hepatic Steatosis
NCT04907721 ·Status: COMPLETED ·Phase: NA
-
Glucagon Resistance in Patients With NAFLD
NCT04042142 ·Status: COMPLETED ·Phase: NA
-
Postprandial Gut Hormone Responses in Patients With Type 1 Diabetes Mellitus
NCT04430946 ·Status: UNKNOWN ·Phase: NA